System Transmission

Top Signal

100#1 JOB

Activity

2162Ripe

+919 today

System

Live1m

Terminal Asset View

stockNASDAQ

AMLX

$13.99-2.71%

Amylyx Pharmaceuticals Inc. - Common Stock

Overripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

3Overripe

Live Analysis Active

Company Mission

Amylyx Pharmaceuticals develops and sells prescription medications for serious neurological diseases, primarily focusing on conditions like amyotrophic lateral sclerosis (ALS). The company creates treatments that aim to slow disease progression and improve patient outcomes. It generates revenue by selling these drugs to patients through healthcare providers and insurance systems, with pricing based on pharmaceutical market standards.

AML

Industry Context

Amylyx operates in the biotechnology and pharmaceutical industry, which focuses on developing treatments for serious medical conditions. This industry involves high research costs, long development timelines, and significant regulatory oversight from agencies like the FDA.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

29Matrix

Market Momentum

52.5— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.0x— Normal Volume

Today's Change

-2.71%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing AMLX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:43 PM UTC

As-of 03-14-2026 18:28 UTC

Develops prescription drugs for neurological diseases and makes money by selling these treatments through hospitals and pharmacies.

No price data available for analysis, suggesting limited recent trading activity or data collection issues showing consolidation pattern.

Biotech sector faces regulatory scrutiny and clinical trial risks, requiring close monitoring of FDA decisions and competitor developments, suggesting competitor developments.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...